Insider trading · Q3 2026 · CIK 1393434

Ocular Therapeutix, Inc (OCUL) insider trading.

In Q3 2026, insiders at Ocular Therapeutix, Inc reported 7 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $333K.

Transactions
7
Purchases (P)
0
Sales (S)
5
Net shares, P minus S
-30,976
Insiders
5
Last filed
2026-09-02

Insiders

InsiderRelationshipTransactionsBuysSales
Dugel PravinDirector, Officer · See Remarks301
Notman DonaldOfficer · Chief Operating Officer101
Heier Jeffrey S.Officer · Chief Scientific Officer101
Nayak SanjayOfficer · Chief Strategy Officer101
Kaiser PeterOfficer · Chief Development Officer101

Transactions

7 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-31Notman DonaldS (D)1,099$10.24366,529Form 4
2026-08-25Dugel PravinG (A)50,092$0744,903Form 4
2026-08-25Dugel PravinG (D)50,092$00Form 4
2026-08-24Dugel PravinS (D)21,649$10.772,525,429Form 4
2026-08-24Heier Jeffrey S.S (D)3,296$10.78318,326Form 4
2026-08-24Nayak SanjayS (D)1,897$10.78326,898Form 4
2026-08-24Kaiser PeterS (D)3,035$10.77264,378Form 4

Transaction codes in this quarter

Get OCUL insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1393434&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · OCUL company page · Ocular Therapeutix, Inc on SEC.gov

Questions

Are insiders buying or selling Ocular Therapeutix, Inc (OCUL)?

In Q3 2026, insiders at Ocular Therapeutix, Inc reported 7 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $333K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Ocular Therapeutix, Inc insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/ocul.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.